Company intelligence / Profile preview

Shandong Runxin Biotechnology

Qufu, Shandong, China

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Shandong Runxin Biotechnology is a leading Chinese manufacturer of sodium hyaluronate, chondroitin sulfate, and dietary supplement products, with offerings ranging from pharmaceutical and cosmetic to food-grade ingredients. The company’s products are widely used in joint, skin, and eye health as well as anti-aging and sports nutrition fields. It holds cGMP, ISO, FDA, and Halal certifications and serves a global customer base with OEM/ODM solutions, but does not operate its own proprietary therapeutic drug pipeline or clinical-stage programs.[3][9][14][15]

Therapeutic areas: OtherOphthalmologyDermatologyRheumatology
Modalities: ProteinBiologicSmall molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Shandong Runxin Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Runxin Biotechnology.

Explore the full profile